This prospective study reported 2 key results: (1) lack of seroconversion following 2 doses of COVID-19 vaccines is an independent predictor of SARS-CoV-2 infection; (2) treatments for IBD were not associated with increased risk of SARS-CoV-2 infection.
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study / F.S. Macaluso, M. Principi, F. Facciotti, A. Contaldo, A. Todeschini, S. Saibeni, C. Bezzio, F. Castiglione, O.M. Nardone, R. Spagnuolo, M.C. Fantini, G. Riguccio, S. Conforti, F. Caprioli, C. Viganò, C. Felice, G. Fiorino, C. Correale, G. Bodini, M. Milla, G. Scardino, M. Vernero, F. Desideri, F. Bossa, M. Guerra, M. Ventimiglia, A. Casà, G. Rizzo, A. Orlando. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - (2023), pp. izad118.1-izad118.5. [Epub ahead of print] [10.1093/ibd/izad118]
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study
F. Caprioli;
2023
Abstract
This prospective study reported 2 key results: (1) lack of seroconversion following 2 doses of COVID-19 vaccines is an independent predictor of SARS-CoV-2 infection; (2) treatments for IBD were not associated with increased risk of SARS-CoV-2 infection.
| File | Dimensione | Formato | |
|---|---|---|---|
|
izad118.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
273.44 kB
Formato
Adobe PDF
|
273.44 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
